Cargando…

Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis

Background: The intrathecal humoral response is the characteristic diagnostic finding in the cerebrospinal fluid (CSF) analysis of patients with multiple sclerosis (MS). Although the average age of MS patients increases, little is known about the sensitivity of diagnostic markers in elderly MS patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Konen, Franz Felix, Hannich, Malte Johannes, Schwenkenbecher, Philipp, Grothe, Matthias, Gag, Konrad, Jendretzky, Konstantin Fritz, Gingele, Stefan, Sühs, Kurt-Wolfram, Witte, Torsten, Skripuletz, Thomas, Süße, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312908/
https://www.ncbi.nlm.nih.gov/pubmed/35884934
http://dx.doi.org/10.3390/biomedicines10071629
_version_ 1784753948634120192
author Konen, Franz Felix
Hannich, Malte Johannes
Schwenkenbecher, Philipp
Grothe, Matthias
Gag, Konrad
Jendretzky, Konstantin Fritz
Gingele, Stefan
Sühs, Kurt-Wolfram
Witte, Torsten
Skripuletz, Thomas
Süße, Marie
author_facet Konen, Franz Felix
Hannich, Malte Johannes
Schwenkenbecher, Philipp
Grothe, Matthias
Gag, Konrad
Jendretzky, Konstantin Fritz
Gingele, Stefan
Sühs, Kurt-Wolfram
Witte, Torsten
Skripuletz, Thomas
Süße, Marie
author_sort Konen, Franz Felix
collection PubMed
description Background: The intrathecal humoral response is the characteristic diagnostic finding in the cerebrospinal fluid (CSF) analysis of patients with multiple sclerosis (MS). Although the average age of MS patients increases, little is known about the sensitivity of diagnostic markers in elderly MS patients. Methods: In this retrospective two-center study, intrathecal free light chains kappa fraction (FLCk IF) and oligoclonal bands (OCB) were studied in a large cohort of patients with early and late onset relapsing (RMS) and progressive (PMS) MS. Furthermore, the humoral immune profile in CSF was analyzed, including the polyspecific intrathecal immune response measured as the MRZ reaction. Results: While the frequency of CSF-specific OCB did not differ between early and late onset RMS and PMS, the sensitivity of positive FLCk IF and absolute FLCk IF values were lower in PMS. The positivity of the MRZ reaction was equally frequent in early and late onset RMS and PMS. PMS patients had higher local IgA concentrations than RMS patients (p = 0.0123). Conclusions: OCB are slightly superior to FLCk IF in progressive MS in terms of sensitivity for detecting intrathecal immunoglobulin synthesis. The MRZ reaction, as the most specific parameter for MS, is also applicable in patients with late onset and progressive MS.
format Online
Article
Text
id pubmed-9312908
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93129082022-07-26 Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis Konen, Franz Felix Hannich, Malte Johannes Schwenkenbecher, Philipp Grothe, Matthias Gag, Konrad Jendretzky, Konstantin Fritz Gingele, Stefan Sühs, Kurt-Wolfram Witte, Torsten Skripuletz, Thomas Süße, Marie Biomedicines Article Background: The intrathecal humoral response is the characteristic diagnostic finding in the cerebrospinal fluid (CSF) analysis of patients with multiple sclerosis (MS). Although the average age of MS patients increases, little is known about the sensitivity of diagnostic markers in elderly MS patients. Methods: In this retrospective two-center study, intrathecal free light chains kappa fraction (FLCk IF) and oligoclonal bands (OCB) were studied in a large cohort of patients with early and late onset relapsing (RMS) and progressive (PMS) MS. Furthermore, the humoral immune profile in CSF was analyzed, including the polyspecific intrathecal immune response measured as the MRZ reaction. Results: While the frequency of CSF-specific OCB did not differ between early and late onset RMS and PMS, the sensitivity of positive FLCk IF and absolute FLCk IF values were lower in PMS. The positivity of the MRZ reaction was equally frequent in early and late onset RMS and PMS. PMS patients had higher local IgA concentrations than RMS patients (p = 0.0123). Conclusions: OCB are slightly superior to FLCk IF in progressive MS in terms of sensitivity for detecting intrathecal immunoglobulin synthesis. The MRZ reaction, as the most specific parameter for MS, is also applicable in patients with late onset and progressive MS. MDPI 2022-07-07 /pmc/articles/PMC9312908/ /pubmed/35884934 http://dx.doi.org/10.3390/biomedicines10071629 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Konen, Franz Felix
Hannich, Malte Johannes
Schwenkenbecher, Philipp
Grothe, Matthias
Gag, Konrad
Jendretzky, Konstantin Fritz
Gingele, Stefan
Sühs, Kurt-Wolfram
Witte, Torsten
Skripuletz, Thomas
Süße, Marie
Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis
title Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis
title_full Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis
title_fullStr Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis
title_full_unstemmed Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis
title_short Diagnostic Cerebrospinal Fluid Biomarker in Early and Late Onset Multiple Sclerosis
title_sort diagnostic cerebrospinal fluid biomarker in early and late onset multiple sclerosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9312908/
https://www.ncbi.nlm.nih.gov/pubmed/35884934
http://dx.doi.org/10.3390/biomedicines10071629
work_keys_str_mv AT konenfranzfelix diagnosticcerebrospinalfluidbiomarkerinearlyandlateonsetmultiplesclerosis
AT hannichmaltejohannes diagnosticcerebrospinalfluidbiomarkerinearlyandlateonsetmultiplesclerosis
AT schwenkenbecherphilipp diagnosticcerebrospinalfluidbiomarkerinearlyandlateonsetmultiplesclerosis
AT grothematthias diagnosticcerebrospinalfluidbiomarkerinearlyandlateonsetmultiplesclerosis
AT gagkonrad diagnosticcerebrospinalfluidbiomarkerinearlyandlateonsetmultiplesclerosis
AT jendretzkykonstantinfritz diagnosticcerebrospinalfluidbiomarkerinearlyandlateonsetmultiplesclerosis
AT gingelestefan diagnosticcerebrospinalfluidbiomarkerinearlyandlateonsetmultiplesclerosis
AT suhskurtwolfram diagnosticcerebrospinalfluidbiomarkerinearlyandlateonsetmultiplesclerosis
AT wittetorsten diagnosticcerebrospinalfluidbiomarkerinearlyandlateonsetmultiplesclerosis
AT skripuletzthomas diagnosticcerebrospinalfluidbiomarkerinearlyandlateonsetmultiplesclerosis
AT sußemarie diagnosticcerebrospinalfluidbiomarkerinearlyandlateonsetmultiplesclerosis